Phospho-Caveolin-1 (Tyr14)抗体特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而，抗体可通过与病毒或**的特异性结合，直接发挥中和病毒的作用。
产品编号xy- 3480R
英文名称Phospho-Caveolin-1 (Tyr14)
中文名称磷酸化细胞质膜微囊蛋白-1抗体
别 名Caveolin-1(Phospho-Tyr14); p-Caveolin-1(Tyr14); Caveolin-1(Phospho-T14); opamine D3 receptor; Caveolin1; Caveolin 1; 3 dopamine receptor; D; Dopamine receptor D3; DRD; ETM1; FET1; Cav-1; ETM1; CAV 1; CAV1; CAV1_HUMAN.
说 明 书100ul
产品类型磷酸化抗体
研究领域肿瘤 细胞生物 **学 信号转导 转录调节因子
抗体来源Rabbit
克隆类型Polyclonal
Phospho-Caveolin-1 (Tyr14)抗体交叉反应 Human, Mouse, Rat,
产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量20kDa
细胞定位细胞浆 细胞膜
性 状Lyophilized or Liquid
浓 度1mg/ml
免 疫 原KLH conjugated synthesised phosphopeptide derived from human Caveolin-1 around the phosphorylation site of Tyr14 [HL(p-Y)TV]:HL(p-Y)TV
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Phospho-Caveolin-1 (Tyr14)抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMedPubMed
产品介绍background:
The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 MAP kinase cascade. CAV1 and CAV2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. By using alternative initiation codons in the same reading frame, two isoforms (alpha and beta) are encoded by a single transcript from this gene. [provided by RefSeq].
Function:
May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Recruits CTNNB1 to caveolar membranes and may regulate CTNNB1-mediated signaling through the Wnt pathway.
Subunit:
Homooligomer. Interacts with GLIPR2, NOSTRIN, SNAP25 and syntaxin. Interacts with rotavirus A NSP4. Interacts (via the N-terminus) with DPP4; the interaction is direct. Interacts with CTNNB1, CDH1 and JUP. Interacts with BMX and BTK.
Subcellular Location:
Golgi apparatus membrane;Peripheral membrane protein. Cell membrane; Peripheral membrane protein. Membrane, caveola; Peripheral membrane protein. Membrane raft. Note=Colocalized with DPP4 in membrane rafts. Potential hairpin-like structure in the membrane. Membrane protein of caveolae.
Tissue Specificity:
Expressed in muscle and lung, less so in liver, brain and kidney.
Post-translational modifications:
The initiator methionine for isoform Beta is removed during or just after translation. The new N-terminal amino acid is then N-acetylated.
Phosphorylated at Tyr-14 by ABL1 in response to oxidative stress.
DISEASE:
Defects in CAV1 are the cause of congenital generalized lipodystrophy type 3 (CGL3) [MIM:612526]; also called Berardinelli-Seip congenital lipodystrophy type 3 (BSCL3). Congenital generalized lipodystrophies are autosomal recessive disorders characterized by a near absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.
Similarity:
Belongs to the caveolin family.
SWISS:
Q03135
Gene ID:
857
Phospho-Caveolin-1 (Tyr14)抗体（antibody,
Ab）是由效应B细胞（效应**B细胞）分泌，机体用于抵御外来物质，如病毒，**等抗原，结构呈“Y”字型的球状蛋白质，仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质，均被称作抗原，因此对于抗抗体（能够结合抗体的抗体）来说，抗体本身也是一种抗原物质。
Phospho-Caveolin-1 (Tyr14)抗体普通抗体重链和轻链的结构
重链结构：普通的**球蛋白具有2条重链（H链），分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型，对应的**球蛋白名称分别为IgM、IgG、IgA、IgD和IgE。
轻链结构： 普通**球蛋白具有2条轻链（L链），分子质量约25kDa，有κ链和λ链两种亚型，这两种轻链决定了Ig的亚型类别（IgG1，IgG2，IgG3，IgG4）。一个天然的Ig分子两条轻链总是相同的，但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同，正常人血清**球蛋白κ链：λ链约为2：1，而在小鼠的比例为20：1。
2.2抗体Fab段和Fc段
IgG经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1个Fc段,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应；经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab’)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段（fragment of antigen binding，Fab），相当于抗体分子的两个臂，由一个完整的轻链和重链的VH和CH1结构域组成。Fc段为可结晶段（fragment crystallizable，Fc）相当于Ig的CH2和CH3结构域，是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区，以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2和CH3的区域，相当于Y字结构下面那一部分。
合格 合格 ALPPL2 胎盘碱性磷酸酶抗体
合格 METTL21C 甲基化样蛋白21C抗体
合格 Phospho-Insulin Receptor Beta (Tyr1361) 磷酸化胰岛素受体β(Tyr1361)抗体
合格 Phospho-PTEN(Ser385) 磷酸化肿瘤抑制基因PTEN抗体
合格 Phospho-delta Opioid Receptor (Ser363) 磷酸化D型受体抗体
合格 Phospho-NFkB p100 (Ser866+Ser870) 磷酸化细胞核因子/k基因结合核因子p100抗体
合格 CCL2 **细胞趋化因子CCL2抗体
合格 Cryptochrome 1 隐花色素蛋白1抗体
合格 合格 CXCL2 巨噬细胞炎症蛋白2（ GRO β）抗体
合格 phospho-KLF5(Ser275) 磷酸化KLF5抗体
合格 Kv4.3 离子通道蛋白Kv4.3抗体
合格 合格 PIWIL1 piwi样1蛋白抗体
合格 ARRB1/Beta-arrestin 1 β-抑制蛋白1抗体
合格 AMPK beta 1/PRKAB1 腺苷单磷酸活化蛋白激酶β1抗体
合格 AMPK beta 2 腺苷单磷酸活化蛋白激酶β2抗体
合格 合格 CYP2C9 细胞色素P450 2C9抗体
合格 KRT81 细胞角蛋白81抗体
合格 Activated Notch1 活化的Notch1蛋白抗体
合格 phospho-Bcl-xL (Ser62) 磷酸化Bcl-xL (Ser62)抗体
合格 合格 MKP1 丝裂原活化蛋白激酶磷酸酶-1抗体
合格 CD158e NK细胞抑制性受体3DL1抗体
合格 Phospho-Cofilin (Ser3) 磷酸化丝切蛋白(Ser3)抗体
合格 Phospho-LRP6 (Ser1490) 磷酸化低密度脂蛋白受体相关蛋白6抗体
合格 Pescadillo Pescadillo抗体
合格 合格 Cytohesin 3 胞粘蛋白3抗体
合格 ADCY3 腺苷酸环化酶3抗体
合格 ADAM2 去整合素样金属蛋白酶2抗体
合格 Phospho-PDGFRA(Tyr754) 磷酸化血小板源性生长因子受体-α抗体
合格 MIG6 有丝分裂原诱导基因6抗体
合格 phospho-Kv4.2 (Thr607) 磷酸化电压门控性钾通道蛋白Kv4.2抗体
合格 合格 Rad51 Rad51抗体
合格 CSGLCAT 硫酸软骨素聚合酶3抗体
合格 Transition Protein 1 真核肽链释放因子3a/eRF3抗体
合格 NMDAR1 离子型谷氨酸受体1抗体
合格 Magphinin 卵母细胞TRO抗体
合格 KCTD16 钾离子通道多聚体结构域蛋白16抗体
合格 合格 QPRT/QAPRTase 喹啉酸磷酸核糖基转移酶抗体
合格 合格 CXCR4 细胞表面趋化因子受体4抗体